Get the Stockscreener App
21.48
3.87%
0.80
Pre-market:
21.25
-0.23
-1.07%
Phibro Animal Health Corp stock is traded at $21.48, with a volume of 396.60K.
It is up +3.87% in the last 24 hours and down -7.89% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$20.68
Open:
$20.59
24h Volume:
396.60K
Relative Volume:
2.25
Market Cap:
$870.02M
Revenue:
$982.01M
Net Income/Loss:
$14.80M
P/E Ratio:
58.05
EPS:
0.37
Net Cash Flow:
$37.02M
1W Performance:
+3.62%
1M Performance:
-7.89%
6M Performance:
+25.32%
1Y Performance:
+90.93%
1-Day Range:
$20.25
$21.82
1-Week Range:
$20.25
$21.82
52-Week Range:
$10.04
$25.98
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
21.48 | 870.02M | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
165.02 | 74.45B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.49 | 42.91B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.24 | 41.98B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.49 | 24.35B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
11.96 | 14.28B | 15.05B | -883.30M | 1.89B | -0.74 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-10-24 | Initiated | JP Morgan | Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
Zacks Research Issues Optimistic Forecast for PAHC Earnings - MarketBeat
Expanding Global Network, Vaccine Sales Support PAHC Stock - Yahoo Finance
Zacks Research Has Positive Forecast for PAHC Q2 Earnings - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Sees Strong Trading VolumeStill a Buy? - MarketBeat
3 Reasons Growth Investors Will Love Phibro (PAHC) - Yahoo Finance Australia
Growth Trends in the Porcine Vaccines Market, Forecast to 2028: Increasing Government Initiatives for Funding Animal Husbandry - GlobeNewswire Inc.
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now? - Yahoo Finance
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by Principal Financial Group Inc. - Defense World
Phibro Animal Health (NASDAQ:PAHC) Raised to Strong-Buy at StockNews.com - Defense World
Phibro Animal Health Gains 83% in a Year: What's Driving the Stock? - MSN
Reasons to Retain Phibro Stock in Your Portfolio Now - MSN
Geode Capital Management LLC Has $11.43 Million Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - MarketBeat
Sanctuary Advisors LLC Has $279,000 Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - MSN
Phibro Animal Health (NASDAQ:PAHC) Downgraded by StockNews.com to “Buy” - Defense World
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance
Limoneira And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
State Street Corp Sells 33,324 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Barclays PLC Purchases 29,271 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by State Street Corp - MarketBeat
Wellington Management Group LLP Trims Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Morgan Stanley Issues Positive Forecast for Phibro Animal Health (NASDAQ:PAHC) Stock Price - MarketBeat
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Bought by Fmr LLC - Defense World
BNP Paribas Financial Markets Grows Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Zacks Research Analysts Boost Earnings Estimates for PAHC - Defense World
Zacks Research Brokers Increase Earnings Estimates for PAHC - MarketBeat
Equities Analysts Set Expectations for PAHC FY2025 Earnings - MarketBeat
Global Veterinary Vaccines Market is Predicted to Cross USD 16 Billion by 2030 | DelveInsight - The Malaysian Reserve
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Stock Rating Lowered by StockNews.com - MarketBeat
Villanova Investment Management Co LLC Sells 31,210 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - MarketBeat
Phibro (PAHC) Down 2.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios - Yahoo Finance
Reasons to Add Phibro Stock to Your Portfolio Right Now - Yahoo Finance
What is Zacks Research's Forecast for PAHC Q1 Earnings? - MarketBeat
Here is Why Growth Investors Should Buy Phibro (PAHC) Now - Yahoo Finance
Phibro Animal Health Co. (NASDAQ:PAHC) Stock Holdings Lifted by Algert Global LLC - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Stock Rating Upgraded by StockNews.com - MarketBeat
PAHC (Phibro Animal Health) 5-Year Dividend Growth Rate : 0.60% (As of Sep. 2024) - GuruFocus.com
PAHC (Phibro Animal Health) Free Cash Flow per Share : $1.00 (TTM As of Sep. 2024) - GuruFocus.com
PAHC (Phibro Animal Health) Effective Interest Rate on Debt % : 6.30% (As of Sep. 2024) - GuruFocus.com
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term - Yahoo Finance
PAHC (Phibro Animal Health) EPS without NRI : $1.40 (TTM As of Sep. 2024) - GuruFocus.com
U.S. Animal Health Market Size, Share | Industry Report 2030 - Grand View Research
Zacks Research Has Pessimistic Outlook of PAHC Q3 Earnings - MarketBeat
PAHC (Phibro Animal Health) 50-Day SMA : $23.16 (As of Nov. 24, 2024) - GuruFocus.com
Atria Investments Inc Has $283,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
PAHC (Phibro Animal Health) FCF Margin % : 1.17% (As of Sep. 2024) - GuruFocus.com
Zacks Research Has Pessimistic Outlook of PAHC Q2 Earnings - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Lowered to Buy Rating by StockNews.com - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Rating Lowered to Buy at StockNews.com - Defense World
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.12%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):